September 21, 2015
Allergan challenges Generic Rytary Patent in USA
Allergan, a Dublin-headquartered pharmaceutical company, confirmed on Monday that it has filed an Abbreviated New Drug Application (ANDA) with the…
pharmaceutical daily
Pharmaceuticals, Biotechnology and Life Sciences
September 21, 2015
Allergan partners with Caregiver Action Network to provide 1000 thank you meals
Allergan has announced a nationwide partnership with the Caregiver Action Network (CAN), a family caregiver organization, to provide thank you meals to 1,000…
September 21, 2015
FDA warns about children under 17 taking tramadol
The U.S. Food and Drug Administration (FDA) has announced that taking tramadol pain medicine for children under 17 can cause…
September 21, 2015
Harald Hampel to Become Anavexs Scientific Advisory Board Member
Anavex Life Sciences Corp., a clinical-stage biopharmaceutical company developing drug candidates to treat Alzheimer’s disease, other central nervous system (CNS)…
September 21, 2015
Quantum Pharma wins Biodose Services contract with Yorkshire and Humber NHS
Quantum Pharma a service-led niche pharmaceutical manufacturer, developer and supplier to the health and care sectors has anounced first large-scale NHS homecare contract…
September 20, 2015
Simulation Plus to provide 50 GastroPlus software licenses to FDA
Simulations Plus, Inc, a provider of consulting services and software for pharmaceutical discovery and development, announced on September 17 that…
September 20, 2015
Safely Dispose Your Unused Medicine on National Prescription Drug Take-Back Day (USA)
DEA Acting Administrator Chuck Rosenberg has announced that the 10th National Prescription Drug Take-Back will take place September 26 from…
September 18, 2015
Bayer in structural reorganization. Jobs to remain stable
The Supervisory Board of Bayer has approved the reorganization proposed by the Board of Management, so that from January 1,…
September 18, 2015
Swissmedic approves Novartis’ new heart failure medicine Entresto
Novartis announced on September 18 that Swissmedic has approved Entresto (sacubitril/valsartan), previously known as LCZ696, to reduce the risk of cardiovascular…
September 18, 2015
Butala Emporium recalls eleven dietary supplements from Baidyanath
FDA announced on September 15 that Butala Emporium, Inc of Jackson Heights, NY, is voluntarily recalling eleven Ayurvedic (dietary) supplements because the products…
You must be logged in to post a comment.